Atezolizumab: beside an established treatment under test

66 studies: an approved drug, surgery or radiation is what the study tests. Page 1 of 1. Open to participants first (40), then studies with results posted, then the rest; newest registration first within each.

• PULSAR Radiotherapy Combined With Immunotherapy for High-Risk Advanced Liver CancerRecruitingNCT07884877Phase 2Report a problem
• Safety and Efficacy of Folic Acid Combined With Atezolizumab and Bevacizumab as First-Line Therapy for Unresectable Hepatocellular CarcinomaNot yet recruitingNCT07835737Phase 1/2Report a problem
• Oral Zinc Supplementation Combined With Targeted Immunotherapy for Unresectable or Advanced Hepatocellular CarcinomaRecruitingNCT07793695Phase 2Report a problem
• Atezolizumab, Bevacizumab, and Tocilizumab in Advanced Hepatocellular CarcinomaNot yet recruitingNCT07774247Phase 2Report a problem
• Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV)RecruitingNCT07770100Phase 2Report a problem
• Comparison of SBRT and SIRT With Combination IO for Locally-advanced, Unresectable HCCs (BIIRTH)RecruitingNCT07293468Phase 2/3Report a problem
• Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 TrialRecruitingNCT07263438Phase 2Report a problem
• A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular CarcinomaRecruitingNCT07246668Phase 2Report a problem
• Partial Immune-boost TACE in unrEseCTable HCC Patients Under Systemic TreatmentNot yet recruitingNCT07168668Phase 2Report a problem
• Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT TrialRecruitingNCT07166406Phase 3Report a problem
• ICIs and Anti-VEGF Antibody/TKIs With or Without Interventional Therapy for Advanced HCCRecruitingNCT07157969Phase 2Report a problem
• Efficacy and Safety of Yttrium-90 Microspheres Selective Internal Radiotherapy Combined with Immune Checkpoint Inhibitors and Anti-angiogenesis Drugs Sequential HAIC for Hepatocellular CarcinomaNot yet recruitingNCT06867432Phase 2Report a problem
• Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCCRecruitingNCT06841172Phase 3Report a problem
• First-line Immunotherapy-based Standard of Care and Local Ablative Treatments for Oligometastatic Non-small Cell Lung Cancer Patients.RecruitingNCT06840782Phase 3Report a problem
• Clinical Trial for Safety and Effectiveness Evaluation of Tarlatamab (AMG757) With Etoposide, Carboplatin and Atezolizumab in Transformed Small Cell Lung Cancer Patients From Adenocarcinoma After EGFR TKI TreatmentRecruitingNCT06830694Phase 2Report a problem
• SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein ThrombosisRecruitingNCT06823375Phase 2Report a problem
• The Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma (HCC)RecruitingNCT06789757Phase 2Report a problem
• Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent ImmunotherapyRecruitingNCT06731270Phase 2Report a problem
• Using Radiotherapy and Immunotherapy to Treat Advanced Liver Cancer Before TransplantRecruitingNCT06725121Phase 1/2Report a problem
• Addition of Thoracic Consolidation Radiotherapy to the Maintenance Immunotherapy for ES-SCLC (STONE-001)Not yet recruitingNCT06719336Phase 3Report a problem
• dTACE-HAIC Combined With Bevacizumab and Atezolizumab for Huge Hepatocellular CarcinomaRecruitingNCT06609863Not applicableReport a problem
• Atezolizumab and BEvacizumab With STereotactic Body Radiotherapy for Advanced Hepatocellular CarcinomaRecruitingNCT06595108Not applicableReport a problem
• Radiotherapy Strategies for Use in Combined Treatment of Small-cell Lung CancerRecruitingNCT06529081Not applicableReport a problem
• Phase I/II Trial of Pemigatinib in Combination With Atezolizumab and Bevacizumab for Treatment of Advanced Cholangiocarcinoma With FGFR2 FusionRecruitingNCT06439485Phase 1/2Report a problem
• Atezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable Hepatocellular CarcinomaRecruitingNCT06339424Phase 2Report a problem
• Metastasis-directed Therapy for Oligometastases of Breast CancerRecruitingNCT06135714Phase 3Report a problem
• Atezolizumab and Bevacizumab With Proton Radiotherapy for Unresectable Hepatocellular CarcinomaRecruitingNCT06133062Phase 2Report a problem
• Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body IrradiationRecruitingNCT06110572Phase 1/2Report a problem
• Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction ImmunochemotherapyNot yet recruitingNCT06031597Phase 3Report a problem
• TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTTRecruitingNCT05984511Not applicableReport a problem
• Atezolizumab and Bevacizumab With Combined Radiotherapy for Advanced Hepatocellular CarcinomaNot yet recruitingNCT05908916Phase 2Report a problem
• Atezolizumab and Bevacizumab Plus TACE-HAIC for Unresectable Advanced HCC: a Phase 2 Clinical TrialRecruitingNCT05751343Phase 2Report a problem
• Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-riskRecruitingNCT05620771Phase 2Report a problem
• Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver MetastasesRecruitingNCT05588388Phase 2Report a problem
• Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung CancerRecruitingNCT05501665Phase 1/2Report a problem
• SBRT With Atezo/Bev for HCCRecruitingNCT05488522Phase 1Report a problem
• Atezolizumab+Bevacizumab+SBRT in Unresectable HCCRecruitingNCT05096715Phase 1Report a problem
• Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or ThoraxRecruitingNCT05092373Phase 1Report a problem
• Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/ImmunotherapyRecruitingNCT04253964Phase 2Report a problem
• Atezolizumab/Bevacizumab Followed by On-demand TACE or Initial Synchronous Treatment With TACE and Atezolizumab/BevacizumabRecruitingNCT04224636Phase 2Report a problem
• A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung CancerActive, not recruitingNCT05091567Phase 3Results postedReport a problem
• Liver Directed RT + Chemo-immunotherapy for ES-SCLCTerminatedNCT04923776Phase 2Results postedReport a problem
• A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract CancerCompletedNCT04677504Phase 2Results postedReport a problem
• A Study Evaluating The Safety, Tolerability, Pharmacokinetics, And Efficacy Of Venetoclax In Combination With Atezolizumab, Carboplatin, And Etoposide In Participants With Untreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC).TerminatedNCT04422210Phase 1Results postedReport a problem
• ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung CarcinomaCompletedNCT04245085Phase 2Results postedReport a problem
• Priming Immunotherapy in Advanced Disease With RadiationCompletedNCT03313804Phase 2Results postedReport a problem
• A Phase II Randomized Trial of Immunotherapy Plus Radiotherapy in Metastatic Genitourinary CancersTerminatedNCT03115801Phase 2Results postedReport a problem
• Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney CancerTerminatedNCT03050060Phase 2Results postedReport a problem
• Hypofractionated Radiation Therapy to Improve Immunotherapy Response in Non-Small Cell Lung CancerCompletedNCT03035890Not applicableResults postedReport a problem
• A Study of Daratumumab in Combination With Atezolizumab Compared With Atezolizumab Alone in Participants With Previously Treated Advanced or Metastatic Non-Small Cell Lung CancerCompletedNCT03023423Phase 1/2Results postedReport a problem
• Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung CancerActive, not recruitingNCT06632327Phase 3Report a problem
• Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular CarcinomaTerminatedNCT05705791Not applicableReport a problem
• Study Evaluating the Benefit of Adding Ipilimumab to the Combination of Atezolizumab and Bevacizumab in Patients With Hepatocellular Carcinoma Receiving First-line Systemic TherapyCompletedNCT05665348Phase 2/3Report a problem
• Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein InvasionCompletedNCT05625893Phase 2Report a problem
• Phase Ib Trial of Infigratinib In Combination With Atezolizumab And Bevacizumab for The Second-Line Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion/AmplificationWithdrawnNCT05510427Phase 1Report a problem
• Efficacy and Safety of T+A+RAD in HCCStatus unknownNCT05396937Phase 2Report a problem
• A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver CancerActive, not recruitingNCT05211323Phase 2Report a problem
• A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and AtezolizumabActive, not recruitingNCT05142696Phase 1/2Report a problem
• SELINEXOR in Combination w/Bevacizumab and Atezolizumab in Newly Diagnosed Advanced Hepatocellular CarcinomaTerminatedNCT05093608Phase 1Report a problem
• A Study to Evaluate Efficacy and Safety of Hepatic Resection for Liver Cancer With PVTT, HVTT or IVCTT After Initial Ate/BevActive, not recruitingNCT04649489Phase 3Report a problem
• Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR TrialSuspendedNCT04402788Phase 2/3Report a problem
• Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive BiomarkerActive, not recruitingNCT04334941Phase 2Report a problem
• Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line ChemotherapyActive, not recruitingNCT03830918Phase 1/2Report a problem
• A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint InhibitorsActive, not recruitingNCT03693014Phase 2Report a problem
• CHEckpoint Inhibition in Combination With an Immunoboost of External Beam Radiotherapy in Solid TumorsCompletedNCT03511391Phase 2Report a problem
• Radium-223 and Atezolizumab in Patients With Urothelial Carcinoma With Bone Metastases Who Have Had Disease Progression After Platinum-Based ChemotherapyTerminatedNCT03208712Early Phase 1Report a problem

← Atezolizumab